Indegene

April 29 (Reuters) - Indegene Ltd INEG.NS:

• MARCH-QUARTER CONSOL PROFIT 797 MILLION RUPEES

• MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 10.03 BILLION RUPEES

• RECOMMENDED A FINAL DIVIDEND OF 2.25 RUPEES PER SHARE

Source text: [ID:]

Further company coverage: INEG.NS

(([email protected];))

April 1 (Reuters) - Indegene Ltd INEG.NS:

• INDEGENE LTD - INDEGENE HEALTHCARE UK SIGNS AGREEMENT TO BUY BUSINESS AND ASSETS OF TRILOGY WRITING AND CONSULTING LTD

• INDEGENE LTD - DEAL SIZE IS GBP 190,679

Source text: ID:nBSE4xhT16

Further company coverage: INEG.NS

(([email protected];))

Jan 29 (Reuters) - Indegene Ltd INEG.NS:

• DEC-QUARTER CONSOL NET PROFIT 1.03 BILLION RUPEES

• DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 9.42 BILLION RUPEES

Further company coverage: INEG.NS

(([email protected];))

Jan 1 (Reuters) - Indegene Ltd INEG.NS:

• SUBSIDIARIES AMALGAMATE TO FORM INDEGENE HEALTHCARE CANADA INC

Source text: ID:nBSE9bSTjd

Further company coverage: INEG.NS

(([email protected];))

Sept 19 (Reuters) - Indegene Ltd INEG.NS:

• INDEGENE LTD - DATAVANT AND INDEGENE PARTNER TO ENHANCE CLINICAL TRIAL RECRUITMENT

Source text: ID:nBSE70zt3B

Further company coverage: INEG.NS

(([email protected];))

** Shares of Indegene INEG.NS rise 1.8% to 560 rupees

** ICICI Securities initiates coverage on life sciences firm with "add" rating; sets PT at 630 rupees, implying 14.5% upside from last close

** Sees strong medium-term growth potential, distinct position in AI-enabled solutions

** Highlights global top-20 pharma clients contribute 64% of co's revenue

** Expects EPS to grow at 14.7% CAGR over FY25–FY28, reaching 25.8 rupees by FY28

** INEG rated "hold" on average by 5 analysts; median PT is 650 rupees – data compiled by LSEG

** Stock down 7.2% YTD

(Reporting by Rudra Pratap Singh in Bengaluru)

(([email protected]))

Sept 5 (Reuters) - Indegene Ltd INEG.NS:

• EXPANDED PRESENCE IN INDIA WITH OPENING OF NEW CENTER IN PUNE

Further company coverage: INEG.NS

(([email protected];))

July 31 (Reuters) - Indegene Ltd INEG.NS:

• INDEGENE JUNE-QUARTER CONSOL NET PROFIT 1.16 BILLION RUPEES

• INDEGENE JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 7.61 BILLION RUPEES

Source text: ID:nNSE26g6hM

Further company coverage: INEG.NS

(([email protected];))

July 11 (Reuters) - Indegene Ltd INEG.NS:

• INDEGENE LAUNCHES NEXT MEDICAL WRITING AUTOMATION

Source text: ID:nnAZN45W3K2

Further company coverage: INEG.NS

(([email protected];;))

** Shares of Indegene INEG.NS gain 1.4% to 591.6 rupees; stock rose as much as 3.5% on the day

** Brokerage Kotak Institutional Equities hikes fair value by 6% to 700 rupees, a Street-high; keeps "buy" rating

** Says growth recovery for FY26 is on track, tariffs uncertainties have not impacted demand significantly

** INEG provides digital services in the biopharma industry; major chunk of its revenue comes from North America

** Kotak expects co to deliver double-digit revenue growth in FY26, backed by strong deals pipeline, better industry outlook and lower client-specific headwinds

** Stock rated "hold" on avg, median PT is 610 rupees - data compiled by LSEG

** INEG down ~2% year-to-date

(Reporting by Manvi Pant in Bengaluru)

(([email protected]; +918447554364;))

** Shares of Indegene Ltd INEG.NS fall 4.5% to 591.80 rupees, set to snap four session gaining streak

** 29.2 mln shares traded in 26 block deals on NSE at 591-599 rupees per share - data compiled by LSEG

** Block deals at 3.3%-4.6% discount to prev close of 619.70 rupees

** Carlyle affiliate CA Dawn Investments was likely to sell 10.2% stake in INEG via block deals worth 14.2 bln rupees ($165.3 mln), CNBC TV18 reports citing sources

** Overall trading volume at record high of 36.4 mln shares, over 141x the 30-day average

** INEG down ~2% YTD

($1 = 85.9040 Indian rupees)

(Reporting by Vijay Malkar)

(([email protected];))

March 19 (Reuters) - Indegene Ltd INEG.NS:

• ANNOUNCED LAUNCH OF A NEW CENTER IN LONDON

Source text: [ID:]

Further company coverage: INEG.NS

(([email protected];;))

Feb 6 (Reuters) - Indegene Ltd INEG.NS:

• EXPANDS FOOTPRINT IN EUROPE, LAUNCHES NEW ENTITY IN SPAIN

Source text: [ID:]

Further company coverage: INEG.NS

(([email protected];;))

Jan 30 (Reuters) - Indegene Ltd INEG.NS:

• DEC-QUARTER CONSOL NET PROFIT 1.10 BILLION RUPEES

• DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 7.20 BILLION RUPEES

Source text: ID:nBSE1YCKyg

Further company coverage: INEG.NS

(([email protected];;))

Jan 9 (Reuters) - Indegene Ltd INEG.NS:

• CLINIOPS ANNOUNCES STRATEGIC PARTNERSHIP WITH INDEGENE

• PARTNERSHIP TO ADVANCE EFFICIENCY OF CLINICAL TRIAL OPERATIONS GLOBALLY

Source text: ID:nBSE6jJ2ns

Further company coverage: INEG.NS

(([email protected];;))

Oct 28 (Reuters) - Indegene Ltd INEG.NS:

• INDEGENE LTD SEPT-QUARTER CONSOL NET PROFIT 917 MILLION RUPEES

• INDEGENE LTD SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 6.87 BILLION RUPEES

Source text: ID:nNSE7skXTS

Further company coverage: INEG.NS

(([email protected];))

Aug 1 (Reuters) - Indegene Ltd INEG.NS:

• JUNE-QUARTER CONSOL NET PROFIT 877 MILLION RUPEES

• JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 6.77 BILLION RUPEES

Source text for Eikon: ID:nBSE9v5nfj

Further company coverage: INEG.NS

(([email protected];))

** Shares of Indegene Ltd INEG.NS rise as much as 3.5% to 589.90 rupees

** INEG, which provides medical commercialization services to pharma firms, announces partnership with Microsoft MSFT.O to help companies scale up the adoption of Generative AI

** Stock on track to gain for third straight day

** More than 1.5 mln shares traded as of 11:57 a.m. IST vs 30-day avg of 870,643 shares, highest vols in nearly a month

** INEG last up 2.7%, stock has gained ~2.4% since listing in May

(Reporting by Meenakshi Maidas in Bengaluru)

(([email protected];))

** Shares of Indegene INEG.NS rise 44.9% in trading debut vs IPO price of 452 rupees

** INEG, provider of digital services for biopharma industry, opens at 655 rupees, stock so far above IPO price

** INEG currently up 27.3% at 137.64 bln rupees ($1.65 bln) valuation

** "Indegene defied market negativity with a spectacular debut on stock exchanges in line with expectations of premium between 40-50%" - Shivani Nyati, head of wealth at Swastika Investmart

** Broader market declines on concerns over outcome of ongoing national elections, sustained selling by foreign investors .BO

** INEG raised 18.42 bln rupees ($220.6 mln) in IPO which had fresh issue of shares worth 7.60 bln rupees, offer for sale of shares worth 10.82 bln rupees - prospectus

** IPO oversubscribed 69.91x last week - exchange data

($1 = 83.5125 Indian rupees)

(Reporting by Rama Venkat in Bengaluru)

(([email protected]; https://twitter.com/ramavenkat0607;))